SCHEMBL7736980

SCHEMBL7736980

[CH2]c1cccc(C(=O)CO)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.38
ERCC5 P28715 3/20 0.37
FEN1 P39748 3/20 0.37
GSK3B P49841 3/20 0.37
ACHE P22303 1/20 0.37
HPGD P15428 4/20 0.37
TDP1 Q9NUW8 3/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPK1 P28482 2/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX15 P16050 1/20 0.37
CES1 P23141 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
TSHR P16473 1/20 0.37
ALOX12 P18054 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12235278 0.84 TDP1 (0.48) FFAR4ERCC5FEN1GSK3BACHE
SCHEMBL2644142 0.82 MAPT (0.46) ACHEHPGDKDM4EMEN1MAPT
SCHEMBL7216443 0.79 HPGD (0.49) HPGDTDP1MEN1MAPTKMT2A
SCHEMBL28759425 0.79 NR4A2 (0.62) HPGDTDP1MAPTKMT2AMAPK1
SCHEMBL108054 0.77 CA12 (0.59) KDM4EMEN1MAPTKMT2ACYP3A4
SCHEMBL6175462 0.77 CA12 (0.54) HPGDTDP1TSHRATML3MBTL1
SCHEMBL30497947 0.77 CA12 (0.59) KDM4EMEN1MAPTKMT2ACYP3A4
SCHEMBL27885569 0.76 HSD17B3 (0.51) TDP1MEN1MAPTKMT2ACES1
SCHEMBL127587 0.76 HSD17B10 (0.59) HPGDTDP1KDM4EMEN1MAPT
SCHEMBL6061554 0.75 HDAC1 (0.45) FFAR4ERCC5FEN1GSK3BACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE37781-E1 VIRICIDES, PROTEASE INHIBITOR DUPONT PHARMACEUTICALS COMPANY 2002-07-02 US disclosed
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed